Login / Signup

Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.

Deborah SchofieldLuke RynehartRupendra N ShresthaSusan M WhiteZornitza Stark
Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2019)
Use of ES in suspected monogenic disorders becomes increasingly cost-effective as the benefits of ES data reanalysis, cascade testing in first-degree relatives, and parental reproductive outcomes are incorporated into modeling.
Keyphrases
  • pulmonary embolism
  • electronic health record
  • type diabetes
  • big data
  • gene expression
  • copy number
  • artificial intelligence
  • deep learning
  • high throughput sequencing